Abstract
Stem cells are a long-lived population of small round cells possessing two remarkable and distinct characteristics, immortality and pluripotency. These two characteristic properties are inherent in “stemness”: (1) immortality is the capacity for indefinite self-renewal, which is duplication or regeneration without the loss of developmental potential, and (2) pluripotency is the ability to differentiate into all the tissues of the adult body. So stem cells can replicate via mitotic division while retaining their undifferentiated state or differentiate into lineage-specific cells. The promise of stem cells now spans a multitude of fields with therapeutic applications for numerous diseases. Major areas of applications include reversal of target organ injury, reversal of senescence for end organ disease, targeting the cancer stem cell to reverse chemoresistance, and corrections for genetic and birth defects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292:154–6.
Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981;78:7634–8.
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–7.
Cowan CA, Klimanskaya I, McMahon J, Atienza J, et al. Derivation of embryonic stem cell lines from human blastocysts. New Engl J Med. 2004;350:1353–6.
Ying QL, Wray J, Nichols J, et al. The ground state of embryonic stem cell self-renewal. Nature. 2008;453:519–23.
Reubinoff BE, Pera MF, Fong CY, et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol. 2000;18:399–404.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.
Takahashi K, Tanabe K, Ohnuki M, Narita M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–72.
Pera MF, Tam PPL. Extrinsic regulation of pluripotent stem cells. Nature. 2010;465:713–20.
Bibikova M, Laurent LC, Ren B, et al. Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell. 2008;2:123–34.
Chambers I, Tomlinson SR. The transcriptional foundation of pluripotency. Development. 2009;136:2311–22.
Alvarez CV, Montserrat G, Garcia-Rendueles MER, et al. Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells. J Mol Endocrinol. 2012;49:R89–111.
Assou S, Le Carrour T, Tondeur S, Ström S, et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells. 2007;25:961–73.
Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol. 2007;25:803–16.
Stewart CL, Kaspar P, Brunet LJ, et al. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature. 1992;359:76–9.
Khoo CP, Pozzilli P, Alison MR. Endothelial progenitor cells and their potential therapeutic applications. Regen Med. 2008;3:863–76.
Ogawa M, LaRue AC, Watson PM, Watson DK. Hematopoietic stem cell origin of connective tissues. Exp Hematol. 2010;38:540–7.
Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007;213:341–7.
Chao Y-H, Wu H-P, Chan C-K, et al. Umbilical cord-derived mesenchymal stem cells for hematopoietic stem cell transplantation. J Biomed Biotechnol. 2012;2012:759503.
Okabe M, Ikawa M, Kominami K, et al. ‘Green mice’ as a source of ubiquitous green cells. FEBS Lett. 1997;407:313–9.
Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393–5.
Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stroma cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.
Wang S, Qu X, Zhao RC. Clinical applications of mesenchymal stem cells. J Hematol Oncol. 2012;5(19):1–9.
Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:321–34.
Leeper NJ, Hunter AL, Cooke JP. Stem cell therapy for vascular regeneration: adult, embryonic and induced pluripotent stem cells. Circulation. 2010;122:517–26.
Prockop DJ. “Stemness” does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin Pharmacol Ther. 2007;82:241–3.
Rochefort GY, Delorme B, Lopez A, et al. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells. 2006;24:2202–8.
Belema-Bedada F, Uchida S, Martire A, et al. Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell. 2008;2:566–75.
Hurst DR, Welch DR. A MSC-ing link in metastasis? Nat Med. 2007;13:1289–91.
Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumor stroma promote breast cancer metastasis. Nature. 2007;449:557–63.
Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cells from human somatic cells. Science. 2007;318:1917–20.
Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313–7.
Huangfu D, Osafune K, Maehr R, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol. 2008;26:1269–75.
Nishikawa S, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol. 2008;9:725–9.
Houghton J, Stoicov C, Noura S, Rogers AB, et al. Gastric cancer originating from bone marrow-derived cells. Science. 2004;306:1568–71.
Bochkov NP, Voronina ES, Kosyakova NV, et al. Chromosome variability of human multipotent mesenchymal stromal cells. Bull Exp Biol Med. 2007;143:122–6.
Kode JA, Mukherjee S, Joglekar MV, et al. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy. 2009;11(4):377–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Fischer, A.C. (2014). Stem Cells: Are They Pertinent to My Research?. In: Kibbe, M., LeMaire, S. (eds) Success in Academic Surgery: Basic Science. Success in Academic Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-4736-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4736-7_11
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4735-0
Online ISBN: 978-1-4471-4736-7
eBook Packages: MedicineMedicine (R0)